Cortical Representation of Hyperalgesia Induced by Nerve Growth Factor

NCT ID: NCT02159170

Last Updated: 2015-01-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-03-31

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Intraepidermal injection of nerve growth factor results in a non-inflammatory hyperalgesia for thermal and mechanical stimuli. This hyperalgesia is similar to the pathological ailments of patients with neuropathic pain. The mechanisms of the cognitive modulation of pain and hyperalgesia are not yet understood in this group of patients. The investigators plan to use NGF injection as a model of non-inflammatory neuropathic pain in healthy subjects to investigate the underlying neuronal mechanisms of this hyperalgesia using functional magnetic resonance imaging and resting state network analysis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-inflammatory Neuropathic Pain Healthy Subjects

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NGF

injection of 50 µl NGF, once into the left volar forearm and injection of 50 µl NaCl (sodium chloride) once into the right volar forearm

Group Type EXPERIMENTAL

NGF injection

Intervention Type BIOLOGICAL

single injection of NGF into the volar forearm / single injection of NaCl into the volar forearm

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NGF injection

single injection of NGF into the volar forearm / single injection of NaCl into the volar forearm

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* no acute or chronic disease
* no acute or chronic pain
* age: 18-60 years
* male
* no medication use

Exclusion Criteria

* metallic parts in the body
* claustrophobia
* drug or substance abuse
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Heidelberg University

OTHER

Sponsor Role collaborator

Prof Herta Flor

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof Herta Flor

Prof. Dr. Herta Flor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Herta Flor, PhD

Role: PRINCIPAL_INVESTIGATOR

Medical Faculty Mannheim, Heidelberg University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Central Institute of Mental Health

Mannheim, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

01ED1010D

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

LOGIN_NGF

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Steroids Versus Gabapentin
NCT01495923 COMPLETED NA
The Role of TRP Channels in CIPN
NCT04415892 RECRUITING NA
Peripheral KV7 Activation for Pain Relief
NCT06971250 COMPLETED EARLY_PHASE1
ACD440 Gel in Peripheral Neuropathic Pain
NCT05416931 COMPLETED PHASE2